Thank you very much, Mr. Chair. Thank you to the witnesses for joining us. Particularly, Minister, thank you for being here.
I have three specific questions, Minister. I would ask that each answer stay within about a minute.
First, could you clarify for the committee what the role of the PMPRB is, some of its limitations, and for the benefit of those watching, the difference between a patented drug and a non-patented or generic drug? It's important to note that the PMPRB is not in charge of the prices of all drugs.